Soy isoflavone prodrugs target CB1 receptor to protect blood vessels from atherosclerosis

A research team at National Taiwan University found that abnormal blood flow activates CB1 receptors in endothelial cells, promoting vascular inflammation and dysfunction. Soy-derived isoflavone prodrugs that inhibit CB1 may help protect blood vessels and prevent atherosclerosis.